Drugs / AAV8-hCocH
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04884594 | Oct 2021 → Dec 2026 expected | cocaine dependence | W. Michael Hooten | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AAV8-hCocH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04884594 ↗ |
| Known as | AAV8-human Cocaine Hydrolase | “Intravenous Administration of AAV8-human Cocaine Hydrolase to Treat Cocaine Use Disorder” NCT04884594 ↗ |
| Route | Intravenous | “single infusion intravenous” NCT04884594 ↗ |